AcquisitionOther
TriSalus Life Sciences, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
TriSalus Life Sciences, Inc. -> target
We are developing and marketing two product lines — Pressure Enabled Drug Delivery ("PEDD™) infusion systems, in use today, and an investigational agent, SD-101, which shows potential to enhance immune system response in the treatment
Open source record (SEC) ↗